Natalizumab for relapsing multiple sclerosis

N Engl J Med. 2003 Apr 17;348(16):1598-9; author reply 1598-9. doi: 10.1056/NEJM200304173481614.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Disease Progression
  • Humans
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Multiple Sclerosis, Relapsing-Remitting / physiopathology
  • Natalizumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Natalizumab